BrightSpring Health Services, Inc. Tangible Equity Unit · BTSGU · Next earnings

BrightSpring Health Services, Inc. Tangible Equity Unit next earnings report

BTSGU's next report date is not on the calendar yet. Here is where the last quarter left off and what remains open. Last quarter: BrightSpring Q3: Pharmacy Growth Offsets IRA Pressure

Date not yet scheduled Healthcare

What the street expects

Consensus for the coming report
Consensus EPS — Calendar consensus
Consensus revenue — Calendar consensus
Report date TBD Not yet on the calendar
Session — Session not yet known

Where BTSGU left off: FY2026 Q3

Full report

BrightSpring Q3: Pharmacy Growth Offsets IRA Pressure

EPS surprise — Reported — vs $0.47
Revenue surprise — Reported — vs $3.88B
Stock move +9.9% Event window
Subsequent drift 0.0% Up to 20 sessions

Management reaffirmed 2026 guidance and signaled 15–20% organic adjusted EBITDA growth in 2027.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • IRA-related pricing and margin pressure in pharmacy.
  • Execution and integration risk from recent acquisitions.
  • Competitive pressure and dependence on continued LDD pipeline and script growth.

Questions analysts left open

  • How gross profit per script and script mix are evolving.
  • Whether the LDD launch pace can remain durable and contribute meaningfully.
  • The scale and recovery timeline of IRA-related revenue pressure.

Ask FN2 about BTSGU next report

Transcript, numbers and history already loaded
What should I watch for in BTSGU's next earnings report?How did BTSGU guide last quarter, and is consensus above or below that?Give me the bull and bear case going into BTSGU earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the BTSGU recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent BTSGU quarters

All BTSGU earnings
+9.9%FY2026 Q3

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.